Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients
NCT ID: NCT04930224
Last Updated: 2021-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2019-07-01
2020-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy
NCT01228981
Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients
NCT04071977
Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients
NCT05631054
Study on the Recovery of Visual Perceptual Function Dysfunction in Patients With Diabetes
NCT07095777
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proliferative Diabetic retinopathy
40 patients with proliferative diabetic retinopathy
The effect of GPER-1 on the formation of diabetic retinopathy
Demonstrating the neuroprotective effect of GPER-1 in the formation of diabetic retinopathy and being a guide for new treatment models
Non-Proliferative Diabetic retinopathy
40 patients with non-proliferative diabetic retinopathy
The effect of GPER-1 on the formation of diabetic retinopathy
Demonstrating the neuroprotective effect of GPER-1 in the formation of diabetic retinopathy and being a guide for new treatment models
Healthy individuals
40 healthy persons
The effect of GPER-1 on the formation of diabetic retinopathy
Demonstrating the neuroprotective effect of GPER-1 in the formation of diabetic retinopathy and being a guide for new treatment models
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The effect of GPER-1 on the formation of diabetic retinopathy
Demonstrating the neuroprotective effect of GPER-1 in the formation of diabetic retinopathy and being a guide for new treatment models
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40 were required to have Non-PDR;
* 40 were required to be healthy, without any systemic disease.
Exclusion Criteria
* Ocular trauma sequelae,
* Pathological myopia,
* Non-diabetic retinopathy,
* A history of previous ocular surgery,
* Endocrine disorders (e.g.,thyroidopathy, adrenal gland disorders, pituitary pathologies),
* Opacities interfering with fundus examination (e.g., corneal opacity, lens opacity, vitreous cloudiness other than diabetic haemorrhage).
35 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdullah Beyoğlu
Assist of Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdullah Beyoğlu, MD
Role: STUDY_CHAIR
Kahramanmaras Sutcu Imam University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abdullah Beyoğlu
Kahramanmaraş, None Selected, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
(Project no: 2019/5-24 M
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.